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Abstract
Background—Self-management interventions are widely implemented in care for patients with 
heart failure (HF). Trials however show inconsistent results and whether specific patient groups 
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respond differently is unknown. This individual patient data meta-analysis assessed the 
effectiveness of self-management interventions in HF patients and whether subgroups of patients 
respond differently.
Methods and Results—Systematic literature search identified randomized trials of self-
management interventions. Data of twenty studies, representing 5624 patients, were included and 
analyzed using mixed effects models and Cox proportional-hazard models including interaction 
terms. Self-management interventions reduced risk of time to the combined endpoint HF-related 
hospitalization or all-cause death (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.71–
0.89), time to HF-related hospitalization (HR, 0.80; 95%CI, 0.69–0.92), and improved 12-month 
HF-related quality of life (standardized mean difference 0.15; 95%CI, 0.00–0.30). Subgroup 
analysis revealed a protective effect of self-management on number of HF-related hospital days in 
patients <65 years (mean number of days 0.70 days vs. 5.35 days; interaction p=0.03). Patients 
without depression did not show an effect of self-management on survival (HR for all-cause 
mortality, 0.86; 95%CI, 0.69–1.06), while in patients with moderate/severe depression self-
management reduced survival (HR, 1.39; 95%CI, 1.06–1.83, interaction p=0.01).
Conclusions—This study shows that self-management interventions had a beneficial effect on 
time to HF-related hospitalization or all-cause death, HF-related hospitalization alone, and elicited 
a small increase in HF-related quality of life. The findings do not endorse limiting self-
management interventions to subgroups of HF patients, but increased mortality in depressed 
patients warrants caution in applying self-management strategies in these patients.
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Heart failure (HF) is one of the most prevalent chronic conditions1 and despite advances in 
medical treatment, patients diagnosed with HF face an increased risk of hospitalization and 
mortality.2 The impact of HF on patients’ lives is substantial, as they are expected to adhere 
daily to drug treatment, lifestyle changes and monitoring of signs and symptoms to prevent 
decompensation.3 Self-management interventions, which aim at improving patients’ 
knowledge and skills to perform those behaviors and manage their condition, have received 
increasing attention in care for patients with HF.
A meta-analysis on the effects of self-management interventions in patients with HF showed 
significant reductions of all-cause and HF-related hospitalization in patients receiving the 
self-management intervention, although there were no effects on mortality and quality of life 
(QoL).4 A more recent systematic review, however, emphasized the heterogeneous findings 
across studies.5 Several recently conducted large randomized controlled trials (RCTs) were 
unable to show beneficial effects of self-management interventions on mortality or 
hospitalization rates,6–9 further illustrating heterogeneity in observed effects.
Part of this heterogeneity may be attributable to varying trial designs, intervention 
components, follow-up periods, or outcome assessments. Since individual RCTs included 
different groups of patients, variations in patient characteristics are another likely source of 
heterogeneity. Specific subgroups of patients might benefit more, or even might not benefit, 
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from self-management interventions. Such knowledge will contribute to targeting self-
management interventions to those groups anticipated to benefit most, which may become 
indispensable in times of decreasing resources.
Sample sizes in individual trials are generally too small to identify factors modifying the 
success of self-management interventions. By combining data from multiple trials, 
individual patient data (IPD) meta-analysis allows a reliable identification of patient 
subgroups with a differential treatment response. Furthermore, IPD meta-analysis enables a 
uniform definition of subgroups across studies, uniform imputation of missing data and 
statistical analysis, and analysis of unreported endpoints.10 Additionally, the main effects of 
included self-management interventions can be pooled and analyzed in a uniform manner.
This IPD meta-analysis aimed to evaluate effectiveness of self-management interventions 
regarding HF-related or generic quality of life, HF-related or all-cause hospitalization, and 
all-cause mortality and to identify subgroups of patients with HF that respond differently to 
such interventions.
Methods
Data Sources and Study Selection
The electronic databases of PubMed, EMBASE, CENTRAL, PsycINFO and CINAHL were 
searched from January 1985 through June 2013, as well as reference lists of systematic 
reviews.
Studies were included if they (1) met the definition of self-management intervention, (2) had 
a RCT design, (3) included patients with an established diagnosis of HF, (4) compared the 
self-management intervention to usual care or another self-management intervention, (5) 
reported data on one or more of the selected outcomes, (6) followed patients for at least six 
months, and (7) were reported in English, Dutch, French, German, Italian, Portuguese, or 
Spanish. Self-management interventions were defined as interventions providing 
information to patients and minimally two of the following components: (1) stimulation of 
sign/symptom monitoring, (2) education in problem solving skills, and enhancement of (3) 
medical treatment adherence, (4) physical activity, (5) dietary intake, or (6) smoking 
cessation. Studies were independently assessed by two researchers (NHJ and HW) on risk of 
bias (low/unclear/high) using three criteria based on the ‘Risk of bias’ tool from the 
Cochrane Collaboration11: (1) random concealed allocation to treatment, (2) intention-to-
treat analysis, and (3) other deviances (e.g., high drop-out, imbalances between groups). Any 
discrepancies were solved through consensus with a third researcher (JCAT). Studies scoring 
a high risk of bias on one or more criteria used from the ‘Risk of bias’ tool11 were defined as 
‘high risk of bias’. Those studies were included in the analysis, but the impact of studies of 
lower methodological quality was assessed in a sensitivity analysis by excluding these 
studies.
Data collection
The principal investigators of selected studies were invited to participate in this IPD meta-
analysis and share their de-individualized raw trial data. For details on the search syntax, 
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collaboration with principal investigators, and a list of all requested variables, we refer to the 
study protocol.12 Data from each trial were checked on range, extreme values, internal 
consistency, missing values, and consistency with published reports. When recoding of 
categorical variables was needed to create uniform categories, principal investigators were 
consulted to ensure correct interpretation of variables. This IPD meta-analysis is exempt 
from formal approval by the Medical Research Ethics Committee of University Medical 
Center Utrecht, since it re-analyzes de-identified data from trials in which informed consent 
has been obtained by principal investigators.
Outcomes
This study focused in the analysis on 8 main outcomes, divided into HF-related outcomes 
and general outcomes. HF-related outcomes were time to the combined endpoint of HF-
related hospitalization or all-cause death, time to first HF-related hospitalization, total days 
of HF-related hospital stay at 12 months, and HF-related quality of life (HF-QoL) at 12 
months (measured with Heart Failure Symptom Scale,13 Kansas City Cardiomyopathy 
Questionnaire,14 MacNew Heart Disease Health-related Quality of Life Instrument,15 or 
Minnesota Living With Heart Failure Questionnaire16). General outcomes were generic QoL 
at 12 months (measured with Short Form Health Survey 1217 or 3618), time to all-cause 
death, time to first all-cause hospitalization, and total days of all-cause hospital stay at 12 
months. In addition, outcomes at 6 months and binary outcomes for mortality and 
hospitalization at 6 and 12 months were collected and analyzed, but are presented in 
Supplemental Tables 1 and 2 as subordinate outcomes.
Patient-specific effect modifiers
Clinically relevant potential effect modifiers (i.e., variables, such as sex or age, that modify 
the effect of self-management interventions) were selected based on the self-management 
literature in HF patients19 and availability of comparable data across trials. The selected 
patient characteristics are presented along with the baseline data in Table 1. We assumed that 
these characteristics could modify the effect of interventions; e.g., self-management 
interventions might be more effective in patients with only primary education compared to 
higher educated patients.
Statistical analyses
Principal investigators were involved in designing a detailed plan for the statistical analysis 
and agreed upon this prior to data analysis (see Supplemental Methods for detailed statistical 
plan). Data from individual studies were merged to create one database. Using multiple 
imputation by chained equations (25 imputations),21 missing values for baseline variables 
and outcomes were imputed within studies. The imputed datasets were analyzed using a 
one-stage approach (i.e., simultaneously analyzing all observations while accounting for 
clustering of observations within studies).22 Results of imputed datasets were pooled using 
Rubin’s rules and presented as the primary results.23
All analyses were performed according to the intention-to-treat principle. For time-to-event 
endpoints, effects of self-management were quantified by estimating hazard ratios (HR) 
using Cox proportional-hazard models, including a frailty term to account for clustering 
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within studies. The continuous outcomes (HF-QoL and generic QoL) were quantified by 
standardized mean differences (SMD) between intervention arms and analyzed using linear 
mixed effects models. To correctly model the presence of overdispersion in count data of 
total days of hospital stay, negative binomial mixed effects models were used to estimate 
relative length of stay. Binary outcome data (all-cause mortality, all-cause, and HF-related 
hospitalization) were analyzed with log-binomial mixed effects models, which estimated 
risk ratios (RR). In case of non-convergence of a model, odds ratios (OR) were estimated 
using a logistic mixed effects model, which is an addition to the published protocol.12 All 
mixed effects models included a random intercept and random slope for the treatment effect 
to take clustering within studies into account.
To assess whether the effect of self-management was modified by patient characteristics, the 
aforementioned models were extended with interaction terms for categorical patient 
characteristics included in Table 1. This was performed for each characteristic separately. If 
there were two or more effect modifiers with p<0.10 for the interaction (likelihood ratio 
test), the interaction terms were included in a multivariable model to estimate the effect of 
self-management within subgroups independent of other relevant effect modifiers. Effect 
modification was considered significant if the interaction term showed p<0.05 in the final 
model.
As a sensitivity analysis, we investigated potential retrieval bias (i.e., selective inclusion of 
studies in the IPD meta-analysis). Published main effects of studies for which we could not 
obtain the original data (and thus were not included in the IPD meta-analysis) were pooled 
in a random effects meta-analysis, together with the main effects of included studies. We 
repeated the main effects analysis by excluding the studies with enhanced usual care. To 
assess the impact of studies of lower methodological quality, a sensitivity analysis was 
performed excluding studies with a high risk of bias. Three additional sensitivity analyses 
assessed the robustness of the effect modifier analysis: (1) complete-case analysis to assess 
the effect of imputing data, (2) analyses restricted to newer studies (recruitment since 2000), 
and (3) excluding studies one-by-one to assess if the observed subgroup effects are 
attributable to a specific study. All analyses were done in R for Windows version 3.1.1 (R 
Development Core Team, Vienna).
Results
Thirty-two studies (n=8737) met the inclusion criteria and principal investigators were 
approached to participate in this IPD meta-analysis. The investigators of five studies could 
not be contacted, IPD of three studies were no longer available, and investigators of four 
studies were not willing to participate. This resulted in inclusion of data of 20 RCTs, 
representing 5624 patients in total.
Patient characteristics for which baseline data were available are presented in Table 1. A 
majority of patients was male (57.2%) and mean age was 69.7 years (SD 12.4). Mean left-
ventricular ejection fraction (LVEF) was 39.2% (SD 18.2) and 26.0% of patients had a 
preserved ejection fraction (≥50%). Median time since diagnosis of HF was 1.6 years (IQR 
0.1–5.4). Baseline characteristics of patients included in this IPD meta-analysis were similar 
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to those of patients in eligible studies that did not provide original data, except for the 
percentage males and current smokers (resp. 63.8% and 11.2% in non-participating studies).
Characteristics of included studies are presented in Table 2. Sample size ranged from 4231 to 
1023 patients.7 The majority of interventions were delivered by a specialized nurse, two 
interventions used a group approach,29,39 and two interventions consisted of telephonic case 
management.36,37 One trial included two intervention arms.7 Duration of the interventions 
ranged from 0.525,30 to 187 months. Two studies provided “enhanced care” to the control 
patients,6,29 consisting of some educational components. These components were judged 
marginal and in line with the education delivered to HF patients in usual care. Consequently, 
these two studies were included in the analysis.
Main effects of self-management interventions
Self-management interventions showed significant effects on several HF-related outcomes 
(Table 3). Interventions reduced risk of time to the combined endpoint of HF-related 
hospitalization or all-cause death (HR, 0.80; 95% confidence interval [CI], 0.71–0.89) and 
time to HF-related hospitalization alone (HR, 0.80; 95% CI, 0.69–0.92). There was a small 
improvement in HF-QoL at 12 months in patients receiving the intervention (SMD, 0.15; 
95% CI, 0.00–0.30). No effects were found for total days in hospital due to HF readmissions 
or any of the general outcomes. Figure 1 shows the effects across studies for HF-QoL, HF-
related hospitalization, and all-cause mortality.
Effects in patient subgroups
In the HF-related outcomes, subgroup analysis revealed significant effect modification by 
age on days in hospital due to HF (Table 3). For younger patients (<65 years), mean number 
of days in hospital due to HF in the intervention group was 0.70 days, while this was 
5.35days in the control group (relative length of stay, 0.09; 95% CI, 0.02–0.38). This 
difference was not found in patients aged 65–80 years (3.30 days in intervention group vs. 
3.84 days in control group, interaction p=0.03). For general outcomes (Table 3), there was 
significant effect modification by comorbid depression on time to all-cause death. While no 
significant effect of self-management was found in patients with no/mild depression on all-
cause death (HR, 0.86; 95% CI, 0.69–1.06), there was a negative effect in patients with 
moderate/severe depression on all-cause death (HR, 1.39; 95% CI, 1.06–1.83, interaction 
p=0.01). In univariable analysis, level of education showed significant effect modification on 
time to first all-cause hospitalization with lower educated patients showing a positive effect 
of the self-management intervention (HR, 0.82; 95% CI, 0.71–0.96, Supplemental Table 3), 
while there was no effect in patients who had completed secondary education (HR, 0.98; 
95% CI, 0.82–1.17), or higher education (HR, 1.26; 95% CI, 0.99–1.60; interaction p=0.02). 
After adjustment for potential effect modification by age, effect modification by level of 
education was no longer significant (interaction p=0.07). Additional analyses of outcomes 
measured at 6 months did not yield different insights (Supplemental Tables 1 and 2).
Sensitivity analyses
Including published effects of eligible studies for which original data could be obtained, did 
not change the primary findings (Supplemental Table 4), neither did the sensitivity analysis 
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of excluding studies with enhanced usual care (Supplemental Table 5). The other sensitivity 
analyses also yielded similar effects. Only when subgroup analysis was repeated without the 
trial by Jaarsma and colleagues,7 effect modification by depression on time to all-cause 
death was no longer statistically significant (interaction p=0.22) and the negative effect for 
patients with moderate/severe depression on all-cause death was no longer present (HR, 
0.63, 95% CI, 0.29–1.34).
Discussion
To our knowledge, this study is the first IPD meta-analysis including sufficiently large 
numbers of HF patients to be able to identify subgroups of patients that respond differently 
to self-management interventions. We observed protective effects of self-management 
interventions on time to the combined endpoint of HF-related hospitalization or all-cause 
death, HF-related hospitalization alone and HF-QoL. Subgroup analyses showed that 
younger patients responded better to self-management in terms of reduced total days of HF-
related hospitalization, and that HF patients with depression showed a reduced survival 
following the self-management intervention.
The beneficial effects found on time to the combined endpoint of HF-related hospitalization 
or all-cause death and on HF-related hospitalization alone have also been reported by 
previous (aggregate data) meta-analyses on similar interventions.4,42 Earlier systematic 
reviews consistently stressed the large heterogeneity across studies regarding effects of self-
management on health-related QoL.5 Our study included several recent large neutral trials6,7 
and was the first to pool the results for HF-QoL and compute an overall effect. Although 
95% confidence intervals were rather wide, we observed a small positive effect for HF-QoL 
at 12 months. In contrast to HF-related outcomes, we found no effects of self-management 
interventions on general outcomes (i.e., generic QoL, all-cause mortality, all-cause 
hospitalization). This is in line with previous meta-analyses.4,42 Thus, it seems that self-
management interventions are particularly effective in HF patients for improving outcomes 
directly related to their disease.
The subgroup analysis showed that younger patients (<65 years) benefited more from self-
management interventions than older patients. Younger patients in intervention groups were 
discharged sooner from hospitalization for HF during follow-up than their counterparts in 
control groups. There was no intervention effect in older patients. Older hospitalized patients 
have an increased risk of functional decline, cognitive dysfunction and generally suffer from 
more comorbid conditions, complicating their overall functioning and recovery time once 
hospitalized.43 Especially older persons are at high risk in the period after hospitalization 
due to deprived sleep, poor nutrition, stress, symptoms, new treatments, and inactivity. 
Equipping patients with self-management skills might not be sufficient in such complex 
situations. Post-discharge instability may need new approaches not only targeting HF itself 
for a safer transition from hospital to home.44 Still, the effect modification by age was not 
consistent across other health outcomes studied and the number of patients aged <65 
included in the analysis was relatively small (n=139). The findings should therefore be 
considered hypothesis-generating.
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Self-management interventions increased the risk of all-cause mortality in patients with 
moderate/severe depression. Sensitivity analyses indicated that this effect was driven by the 
largest study included in this IPD meta-analysis.7 The authors of that study reported a 
similar trend of their intervention for patients with depressive symptoms in their subgroup 
analysis.45 These findings question the suitability of generic self-management interventions 
in HF patients with depressive symptoms. Depression is often associated with reduced 
motivation, which might compromise adherence to medication regimen and lifestyle 
changes,46 particularly if multiple comorbid conditions (and treatment) need to be self-
managed. These patients may be burdened with self-managing their HF. Increased mortality 
following self-management interventions might therefore be caused by suboptimal 
(self-)management of their illnesses, including HF. Interestingly, the negative effect was 
limited to all-cause mortality. In the five studies that measured depression, self-management 
interventions showed an overall HR of 0.95 on time to HF-related hospitalization (95% CI, 
0.94–0.97) and subgroup analysis did not reveal a differential treatment effect between 
patients with and without depression (HR depression, 1.00; 95% CI, 0.74–1.35; HR without 
depression, 0.92; 95% CI, 0.71–1.18; interaction p=0.64). With no clear explanation for 
reduced survival in HF patients with depression, caution is warranted before applying self-
management strategies in care for those patients. Patients with depressive symptoms might 
need additional psychological interventions or medication before initiating self-management 
interventions.47 Screening HF patients on symptoms of depression might help to determine 
to what extent attention should be paid to self-management skills or additional psychological 
interventions in the treatment plan.
Previous subgroup analyses in three large RCTs have shown that self-management 
interventions might be more effective for patients with low socio-economic status. DeWalt 
and colleagues found that only patients with low literacy showed a positive effect on HF-
related hospitalizations after self-management support.6 A Dutch self-management trial 
found greatest improvements in health-related QoL in patients with lower education.48 The 
third trial showed that patients with reduced income benefitted most from self-management.8 
The pattern across studies generates the hypothesis that patients with a lower socio-
economic status may benefit most from self-management interventions. Similarly, our 
analyses indicate a protective effect of self-management on time to first all-cause 
hospitalization in patients with lower education. However, after adjusting for other potential 
effect modifiers, this effect did not reach statistical significance.
This IPD meta-analysis was one of the first attempts to pool individual patient data on self-
management interventions for patients with HF. The study included sufficient patients 
(n=5624) to analyze treatment effects in patient subgroups and applied robust statistical 
modelling according to a pre-specified plan. Reported effects were found across cultures and 
healthcare settings. Nevertheless, this study has several limitations that deserve further 
discussion. First, despite numerous efforts to reach all principal investigators, we were 
unable to include all 32 eligible trials. Inclusion of 62.5% (20/32) of eligible trials is 
relatively high compared to IPD meta-analyses on similar interventions.49 Including 
published results of trials for which no IPD were available did not change main effects, but 
this could not be checked for the subgroup analysis due to limited published subgroup data. 
Second, included self-management interventions differed in terms of intensity, duration, 
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mode, and content. Although reported effects were found for self-management interventions 
in any setting, specific types of interventions might work better for specific subgroups of 
patients. Addressing the question “what works for whom?” deserves attention in subsequent 
research. Third, this IPD meta-analysis was highly dependent on data previously collected in 
individual studies which limited choice of potential effect modifiers to be studied. Individual 
trials indicated that self-management interventions might be more effective in non-adherers 
to regimens25 or in patients with better cognitive status.48 We could not analyze those 
potential effect modifiers, since variables were not collected in all studies. If uniform 
standards for baseline variables were established, a meaningful comparison of patient 
subgroups across studies may provide further insight into patient characteristics modifying 
treatment effects. Finally, although all (subgroup) analyses were pre-planned and 
documented in our protocol,12 their large number increases the risk of false-positive 
findings. Our subgroup analysis was exploratory in nature and not intended to demonstrate 
causal mechanisms. Causal mechanisms of subgroup effects need to be completely 
understood before any final conclusions can be drawn. Validation of our findings in large 
trial databases may confirm our subgroup findings.
Conclusion
We found that despite diversity in intensity, content, and personnel delivering the 
intervention, self-management interventions in patients with HF improve outcomes directly 
related to their disease. Although self-management interventions might be more effective in 
younger patients in reducing length of hospital stay, we did not observe consistent subgroup 
effects across different health outcomes. This study does not endorse limiting self-
management interventions to specific subgroups of HF patients, but increased mortality in 
depressed patients warrants caution in applying self-management strategies in these patients.
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Figure 1. 
Forest plot of effects of self-management interventions on heart failure-related quality of 
life, heart failure-related hospitalization, and all-cause mortality.
CI indicates confidence interval; HR, hazard ratio; and SMD, standardized mean difference.
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Table 1
Baseline characteristics of heart failure patients included in individual patient data meta-analysis.
Control Intervention Total
Sample size, n 2674 2950 5624
Sex
  Male 1505 (56.2) 1711 (58.0) 3126 (57.2)
  Female 1169 (43.7) 1239 (42.0) 2408 (42.8)
Age, y 69.9 ± 12.3 69.6 ± 12.4 69.7 ± 12.4
  <65 years 796 (29.8) 917 (31.1) 1713 (30.5)
  65–80 years 1358 (50.8) 1491 (50.5) 2849 (50.7)
  >80 years 520 (19.4) 542 (18.4) 1062 (18.9)
Systolic dysfunction: LVEF 39.7 ± 18.4 38.7 ± 18.1 39.2 ± 18.2
  >35% LVEF 805 (48.8) 903 (47.3) 1708 (48.0)
  ≤35% LVEF 846 (51.2) 1008 (52.7) 1854 (52.0)
NYHA class
  NYHA I & II 1141 (45.2) 1317 (47.0) 2458 (46.1)
  NYHA III 899 (35.6) 1065 (38.0) 1964 (36.9)
  NYHA IV 484 (19.2) 422 (15.0) 906 (17.0)
Comorbidity index*
  No comorbid conditions 401 (16.7) 556 (20.7) 957 (18.8)
  Comorbid conditions in 1 cluster 925 (38.6) 991 (36.9) 1916 (37.7)
  Comorbid conditions in >1 cluster 1070 (44.7) 1136 (42.3) 2206 (43.4)
Depression†
  No/mild depression 959 (73.9) 1169 (68.8) 2128 (71.0)
  Moderate/severe depression 339 (26.1) 531 (31.2) 870 (29.0)
Level of education
  Primary education or below 807 (42.3) 910 (39.4) 1717 (40.7)
  Secondary education 711 (37.3) 939 (40.6) 1650 (39.1)
  Higher education 388 (20.4) 461 (20.0) 849 (20.1)
Years since diagnosis (median and interquartile range) 2.0 (0.1–6.0) 1.3 (0.1–5.2) 1.6 (0.1–5.4)
  <1 year diagnosed 400 (41.3) 619 (46.2) 1019 (44.1)
  1–2 years diagnosed 118 (12.2) 171 (12.8) 289 (12.5)
  >2 years diagnosed 451 (46.5) 551 (41.1) 1002 (43.4)
Living status
  Living with others 1064 (75.2) 1076 (73.2) 2140 (74.2)
  Living alone 350 (24.8) 393 (26.8) 743 (25.8)
Body mass index 28.2 ± 6.9 27.9 ± 6.4 28.0 ± 6.6
  <25 483 (34.2) 647 (36.1) 1130 (35.3)
  25–29.99 508 (36.0) 611 (34.1) 1119 (35.0)
  ≥30 420 (29.8) 532 (29.7) 952 (29.7)
Smoking status
  Current non-smoker 933 (79.9) 993 (82.1) 1926 (81.1)
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Control Intervention Total
  Current smoker 234 (20.1) 216 (17.9) 450 (18.9)
LVEF indicates left ventricular ejection fraction; and NYHA, New York Heart Association.
Values are n(%), mean±SD or median(interquartile range).
*Categories in the present IPD meta-analysis are based on clusters of the Cumulative Illness Rating Scale.20
†
Based on validated cut-off scores of instrument used in each specific study.
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